Earnings History Data for Brickell Biotech, Inc. (BBI) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.

Brickell Biotech, Inc.

Brickell Biotech, Inc. is a clinical-stage pharmaceutical company. It is focused on developing prescription therapeutics for treatment of skin diseases. The company's pipeline consists of therapeutics for hyperhidrosis, cutaneous T-cell lymphoma, psoriasis, and other prevalent severe skin diseases. Its products include Prozac(R), Gemzar(R), Cialis(R), Evista(R), Talz(R), Humulin(R), Cymbalta(R), Dysport(R), Juvederm(R) and Kybella(R). Brickell Biotech Inc., formerly known as Vical Incorporated, is based in San Diego, United States.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
11-08-2022 AH 4:00 PM ET
(Aug 11)		 BBI Brickell Biotech, Inc. 8.62 -0.01 -1.48 -7.21 Brickell Biotech GAAP EPS of -$0.01 beats by $1.43, revenue of $4.32M beats by $1.18M
[8/11/2022 4:11 PM]		 3.39 0.12 
(3.67%)		 3.36 0.09 
(2.75%)		 2.88 - 37.35 85,714 470,000 3,772
12-05-2022 AH 4:05 PM ET
(May 12)		 BBI Brickell Biotech, Inc. 25.57 -0.08 -0.06 -0.15 Brickell Biotech GAAP EPS of -$0.08 misses by $0.02, revenue of $0.09M misses by $0.05M
[5/12/2022 4:03 PM]		 0.1859 -0.02 
(-10.15%)		 0.19 -0.02 
(-9.62%)		 0.18 - 1.04 4,601,701 7,400,000 380,273
15-03-2022 PM Before the open
(Mar 15)		 BBI Brickell Biotech 28.00 -0.06 -0.09 0.00 Brickell Biotech GAAP EPS of -$0.06 beats by $0.03, revenue of $0.1M misses by $0.05M
[3/15/2022 7:33 AM]		 0.2428 0.0 
(0.08%)		 0.24 0.0 
(1.05%)		 0.20 - 1.40 562,789 7,803,405 1,071
09-11-2021 AH 4:00 PM ET
(Nov 9)		 BBI Brickell Biotech, Inc. 46.20 -0.16 -0.11 -0.15 Brickell Biotech EPS misses by $0.03, misses on revenue
[11/9/2021 4:10 PM]		 0.3520 -0.05 
(-12.00%)		 0.38 -0.03 
(-6.25%)		 0.35 - 1.70 6,438,505 6,290,000 437,553
12-08-2021 AH 4:00 PM ET
(Aug 12)		 BBI Brickell Biotech, Inc. 55.10 -0.16 -0.11 -0.43 Brickell Biotech EPS misses by $0.03, beats on revenue
[8/12/2021 4:04 PM]		 0.6578 -0.03 
(-4.90%)		 0.67 -0.02 
(-3.01%)		 0.47 - 1.70 824,453 590,000 26,751
13-05-2021 AH 4:00 PM ET
(May 13)		 BBI Brickell Biotech, Inc. 60.98 -0.15 -0.12 -0.45 Brickell Biotech EPS misses by $0.03
[5/13/2021 4:20 PM]		 0.8259 -0.02 
(-2.84%)		 0.85 0.0 
(0.00%)		 0.47 - 2.61 845,589 790,000 15,839
09-03-2021 AH 4:00 PM ET
(Mar 9)		 BBI Brickell Biotech, Inc. 62.61 -0.15 -0.08 -1.38 Brickell Biotech reports Q4 results
[3/9/2021 4:04 PM]		 1.08 -0.14 
(-11.48%)		 1.07 -0.15 
(-12.30%)		 0.47 - 2.61 2,460,263 2,333,141 554,404
12-11-2020 AH 4:00 PM ET
(Nov 12)		 BBI Brickell Biotech, Inc. 27.65 -0.15 -0.17 -2.27 Brickell Biotech reports Q3 results
[11/12/2020 4:03 PM]		 0.5296 -0.01 
(-1.49%)		 0.5194 -0.02 
(-3.39%)		 0.47 - 3.98 1,287,856 1,701,878 61,189